ProPhase Labs
PRPH
PRPH was delisted on the 2nd of January, 2026.
27 hedge funds and large institutions have $4.23M invested in ProPhase Labs in 2024 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 4
0.01% more ownership
Funds ownership: 0.91% → 0.92% (+0.01%)
7% less funds holding
Funds holding: 29 → 27 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
42% less capital invested
Capital invested by funds: $7.27M → $4.23M (-$3.04M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$77.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$38.3K |
| 3 |
SC
Sykon Capital
Harrison,
New York
|
+$35.8K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$33.8K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$29.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SW
SVB Wealth
Boston,
Massachusetts
|
-$199K |
| 2 |
RWP
RWA Wealth Partners
Newton,
Massachusetts
|
-$92K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$15.9K |
| 4 |
Renaissance Technologies
New York
|
-$15.2K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$8.81K |
PRPH Hedge Fund Activity: Q3 2024 in Review
27 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q3 2024, worth a combined $4.23M — down 42% from $7.27M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PRPH and 4 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.
The largest buyer was HighTower Advisors, adding an estimated $77.9K. The largest seller was SVB Wealth, exiting entirely with an estimated $199K sold.
- 27 institutional investors held ProPhase Labs (PRPH) as of Q3 2024, down from 29 in Q2 2024.
- Funds reported $4.23M of ProPhase Labs stock for Q3 2024, down 42% quarter-over-quarter.
- 4 funds opened new ProPhase Labs positions in Q3 2024 and 6 closed out, a net change of -2 holders.
- The largest ProPhase Labs buyer in Q3 2024 was HighTower Advisors, an estimated $77.9K added.
- The largest ProPhase Labs seller in Q3 2024 was SVB Wealth, an estimated $199K sold.
Based on aggregated 13F filings for Q3 2024.